The number of people with susceptibility test result for rifampicin in Cyprus
Cyprus: The number of people with susceptibility test result for rifampicin was 29 in 2021. ▼ Falling
Latest (2021)
29
Change on year
up 16.0%
World rank
128th
of 155 countries
All-time high
47
in 2019
All-time low
25
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Cyprus, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Cyprus stood at 29.
The figure is up 16.0% on the previous year and down 12.1% over five years.
Cyprus ranks 128th of 155 countries on this measure, in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Cyprus, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 33 | — |
| 2018 | 33 | +0.0% |
| 2019 | 47 | +42.4% |
| 2020 | 25 | -46.8% |
| 2021 | 29 | +16.0% |
Cyprus compared with similar countries
- Cyprus's 29 is below the median for high income countries, which is 142, 20% of the median. (61 countries reporting)
- Cyprus's 29 is below the median for Europe & Central Asia, which is 229.5, 13% of the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 37.67 | 33 | 47 | 3 |
| 2020s | 27 | 25 | 29 | 2 |
Countries ranked near Cyprus
- 125 Ireland 40 compare
- 126 Guam 35 compare
- 127 Marshall Islands 31 compare
- 129 Micronesia, Federated States of 27 compare
- 129 Malta 27 compare
- 131 United Arab Emirates 23 compare
More health data for Cyprus
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.51 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,325 deaths per 1,000 people (2090)
- Number of infants who die before age 1 7 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.0526 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0263 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.0182 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Cyprus?
- The number of people with susceptibility test result for rifampicin in Cyprus was 29 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Cyprus?
- The highest recorded value was 47 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Cyprus?
- The lowest recorded value was 25 in 2020.
- How does Cyprus rank for the number of people with susceptibility test result for rifampicin?
- Cyprus ranks 128th out of 155 countries with data for 2021.
- Where does this Cyprus data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).